Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Open-label, Non-comparative, Non-randomized Clinical Trial of the Safety and Tolerability of MMH-522 in Healthy Volunteers

NCT07754279 is registered in ClinicalTrials.gov with Materia Medica Holding as lead sponsor.

NCT NCT07754279
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07754279 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Open-label, Non-comparative, Non-randomized Clinical Trial of the Safety and Tolerability of MMH-522 in Healthy Volunteers
Lead sponsor
Materia Medica Holding
Phase
Phase 1
Overall status
Completed
Start date
February 12, 2026
Completion date
May 7, 2026
Enrollment
16 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cough